Company Monitoring Page for Zafgen

latest headlines for company on cafepharma

A battered Zafgen seeks strategic options, prophesying ongoing study will unlikely lift FDA hold on diabetes drug
Endpoints
Thu, 09/5/19 - 10:32 am
Tags:
Zafgen, diabetes, FDA, ZGN-1061
Zafgen has something to cheer as diabetes drug makes the cut in PhII study, quelling cardio safety fears
Endpoints
Thu, 01/17/19 - 09:40 am
Tags:
Zafgen, diabetes, clinical trials, ZGN-1061
FDA Slaps Clinical Hold on Zafgen’s Lead Product Over Safety Concerns
BioSpace
Mon, 11/26/18 - 12:30 pm
Tags:
Zafgen, clinical trials, FDA, diabetes, ZGN-1061, type 2 diabetes
Zafgen starts comeback with first data on replacement weight loss drug
Fierce Biotech
Fri, 05/5/17 - 10:27 am
Tags:
Zafgen, obesity, beloranib, ZGN-1061
In the Spirit of the Olympics: On and Off the Pharma Podium
PharmExec
Sat, 08/13/16 - 06:44 pm
Tags:
Shire, Xiidra, Bayer, JNJ, beloranib, Zafgen, GSK, Valeant Pharmaceuticals
Zafgen shares drop more than 40% as drug focus shifted
Marketwatch
Tue, 07/19/16 - 10:05 pm
Tags:
Zafgen, beloranib, ZGN-1061, obesity
Zafgen up 6% after weight loss drug has positive late-stage trial results
Marketwatch
Mon, 06/13/16 - 11:28 am
Tags:
Zafgen, obesity, beloranib, diabetes
​Hopes rise for FDA approval of Zafgen’s fat-busting drug among analysts, investors
Bizjournals.com
Wed, 05/11/16 - 06:35 pm
Tags:
FDA, Zafgen
Zafgen: Resolution On FDA Issues Weighs On Equity
Seeking Alpha
Sun, 03/13/16 - 01:26 pm
Tags:
Zafgen, earnings
The Top 4 Biopharma Movers of the Past Week
24/7 Wall St
Sun, 02/21/16 - 11:39 am
Tags:
Ocular Therapeutix, Regulus, Zafgen, Aerie Pharma
Zafgen Soars on Positive Phase 2 Results
24/7 Wall St
Thu, 02/18/16 - 09:42 am
Tags:
Zafgen, clinical trials, beloranib, obesity, type 2 diabetes
Zafgen Surges as New Drug Findings May Help Restart FDA Review
Bloomberg
Thu, 01/21/16 - 09:40 am
Tags:
Zafgen, FDA, beloranib
Zafgen Inc Surges on Positive One-Of-A-Kind Drug Trial Results
Bidness, ETC
Wed, 01/20/16 - 08:43 am
Tags:
Zafgen, clinical trials, beloranib, Prader-Willi Syndrome
4 Top FDA Decisions Expected in Q1
24/7 Wall St
Mon, 01/4/16 - 10:05 am
Tags:
FDA, Zafgen, beloranib, Biomarin, Peg-Pal, PB272, Puma Biotechnology, Aquinox, AQX-1125
Top 6 BioPharma Movers of the Week
24/7 Wall St
Sat, 12/5/15 - 12:49 pm
Tags:
Anavex, Aeterna Zentaris, Arena Pharmaceuticals, Foamix, Invivo Therapeutics, Zafgen
FDA orders Zafgen to halt clinical trial for obesity drug
Boston Globe, MA
Thu, 12/3/15 - 09:51 pm
Tags:
FDA, obesity, clinical trials, Zafgen, beloranib
Zafgen shares crash after second patient in pivotal obesity study dies
Fierce Biotech
Wed, 12/2/15 - 09:22 am
Tags:
Zafgen, beloranib, obesity
6 BioHealth Movers That Now Cannot Be Ignored
24/7 Wall St
Sun, 11/22/15 - 01:33 pm
Tags:
Clovis Oncology, KaloBios, Celladon, Sarepta Therapeutics, Zafgen, Valeant Pharmaceuticals
Zafgen says FDA will still review data from trial despite patient death
Bizjournals.com
Thu, 10/22/15 - 10:01 am
Tags:
Zafgen, FDA, clinical trials, belornib, Prader-Willi Syndrome
Zafgen finally breaks its silence, says it's probing death of a patient
Fierce Biotech
Wed, 10/14/15 - 02:20 pm
Tags:
Zafgen, Prader-Willi Syndrome, beloranib

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.